163 related articles for article (PubMed ID: 26213908)
41. Synergistic Activity of Lupinifolin in Combinations with Antibiotics Against
Rattanakiat S; Kaewchang K; Thongsang S; Jaruchotikamol A; Pulbutr P
Pak J Biol Sci; 2021 Jan; 24(6):656-662. PubMed ID: 34486341
[TBL] [Abstract][Full Text] [Related]
42. Antimicrobial resistance profile of Staphylococcus aureus and its in-vitro potential inhibition efficiency.
Alarjani KM; Skalicky M
J Infect Public Health; 2021 Dec; 14(12):1796-1801. PubMed ID: 34756813
[TBL] [Abstract][Full Text] [Related]
43. Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates.
Abdelraheem WM; Khairy RMM; Zaki AI; Zaki SH
Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):54. PubMed ID: 34419054
[TBL] [Abstract][Full Text] [Related]
44. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus at a tertiary care hospital: implications for clinical therapy.
Saxena S; Singh T; Dutta R
J Commun Dis; 2012 Jun; 44(2):97-102. PubMed ID: 25151754
[TBL] [Abstract][Full Text] [Related]
45. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of constitutive and inducible resistance to clindamycin in clinical samples of Staphylococcus aureus from a tertiary hospital.
Bottega A; Rodrigues Mde A; Carvalho FA; Wagner TF; Leal IA; Santos SO; Rampelotto RF; Hörner R
Rev Soc Bras Med Trop; 2014; 47(5):589-92. PubMed ID: 25467260
[TBL] [Abstract][Full Text] [Related]
47. Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains.
Laohavaleeson S; Tessier PR; Nicolau DP
Antimicrob Agents Chemother; 2008 Jul; 52(7):2389-94. PubMed ID: 18411322
[TBL] [Abstract][Full Text] [Related]
48. Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus isolated from clinical samples at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia.
Dilnessa T; Bitew A
BMC Infect Dis; 2016 Aug; 16():398. PubMed ID: 27506613
[TBL] [Abstract][Full Text] [Related]
49. A high frequency of macrolide-lincosamide-streptogramin resistance determinants in Staphylococcus aureus isolated in South Korea.
Kim HB; Lee B; Jang HC; Kim SH; Kang CI; Choi YJ; Park SW; Kim BS; Kim EC; Oh MD; Choe KW
Microb Drug Resist; 2004; 10(3):248-54. PubMed ID: 15383170
[TBL] [Abstract][Full Text] [Related]
50. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci.
Fiebelkorn KR; Crawford SA; McElmeel ML; Jorgensen JH
J Clin Microbiol; 2003 Oct; 41(10):4740-4. PubMed ID: 14532213
[TBL] [Abstract][Full Text] [Related]
51. A review of in-vitro antibacterial activity of quinupristin/dalfopristin against methicillin-susceptible and -resistant Staphylococcus aureus.
Low DE; Nadler HL
J Antimicrob Chemother; 1997 May; 39 Suppl A():53-8. PubMed ID: 9511063
[TBL] [Abstract][Full Text] [Related]
52. Antimicrobial activity of geranium oil against clinical strains of Staphylococcus aureus.
Bigos M; Wasiela M; Kalemba D; Sienkiewicz M
Molecules; 2012 Aug; 17(9):10276-91. PubMed ID: 22929626
[TBL] [Abstract][Full Text] [Related]
53. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
[TBL] [Abstract][Full Text] [Related]
54. Molecular basis of resistance to macrolides, lincosamides and streptogramins in Staphylococcus hominis strains isolated from clinical specimens.
Szczuka E; Makowska N; Bosacka K; Słotwińska A; Kaznowski A
Folia Microbiol (Praha); 2016 Mar; 61(2):143-7. PubMed ID: 26253583
[TBL] [Abstract][Full Text] [Related]
55. [Investigation of antibiotic resistance patterns and reduced vancomycin susceptibilities of methicillin-resistant Staphylococcus aureus isolates: a multi-center study].
Çıkman A; Aydın M; Gülhan B; Parlak M; Gültepe B; Kalaycı Y; Bayındır Bilmen F; Solmaz S; Özekinci T
Mikrobiyol Bul; 2015 Apr; 49(2):240-8. PubMed ID: 26167824
[TBL] [Abstract][Full Text] [Related]
56. [Resistance to macrolide antibiotics found in methicillin-resistant Japanese clinical isolates of Staphylococcus aureus in 1996].
Nakamura A; Taniguchi K; Tsurubuchi K; O'Hara K; Sawai T
Jpn J Antibiot; 1998 Jul; 51(7):494-500. PubMed ID: 9755433
[TBL] [Abstract][Full Text] [Related]
57. [The correlation between phenotypes and genotypes of macrolides, lincosamides and streptogramins B resistance in Staphylococcus aureus].
Młynarczyk G; Młynarczyk A; Szymanek K; Bilewska A; Luczak M
Med Dosw Mikrobiol; 2007; 59(1):17-25. PubMed ID: 17601027
[TBL] [Abstract][Full Text] [Related]
58. The prevalence of genotypes that determine resistance to macrolides, lincosamides, and streptogramins B compared with spiramycin susceptibility among erythromycin-resistant Staphylococcus epidermidis.
Juda M; Chudzik-Rzad B; Malm A
Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):155-60. PubMed ID: 27008373
[TBL] [Abstract][Full Text] [Related]
59. Multidrug and vancomycin resistance among clinical isolates of
Olufunmiso O; Tolulope I; Roger C
Afr Health Sci; 2017 Sep; 17(3):797-807. PubMed ID: 29085408
[TBL] [Abstract][Full Text] [Related]
60. Correlation of agar dilution and VITEK2 system for detection of resistance to macrolides, lincosamides and pristinamycin among Staphylococcus aureus and Staphylococcus epidermidis: association with genotypes.
Bémer P; Juvin ME; Corvec S; Ros A; Drugeon H
Clin Microbiol Infect; 2005 Aug; 11(8):656-61. PubMed ID: 16008619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
